drugset / Trial / NCT00249886

Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents

NCT00249886

Phase 3 Withdrawn 60 enrolled Sunnybrook Health Sciences Centre
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate whether it is advantageous for adolescents who have recovered from depression after a 6 to 12 week course of antidepressant treatment to stay on the treatment a further 6 months or is it just as helpful to stop the medication after recovery. The hypothesis is that adolescents with major depression who recover from the 6 to 12 week trial of citalopram will be less likely to have a recurrence of depression over a 6 month period if continued on the citalopram as compared to those who discontinue the medication.

Timeline

Start
2002-09
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule